Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dalibor Valik

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Biomed Research International|September 5, 2015
B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related CachexiaMichal Rihacek, Julie Bienertova-Vasku, Dalibor Valik, et al.
Human Mutation|March 17, 2004
BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech RepublicLenka Foretova, Eva Machackova, Marie Navratilova, et al.
Anaerobe|June 1, 2011
Surface-enhanced laser desorption ionization/time-of-flight (SELDI-TOF) mass spectrometry (MS) as a phenotypic method for rapid identification of antibiotic resistanceLenka Dubska, Katerina Pilatova, Monika Dolejska, et al.
Journal of Pediatric Hematology/Oncology|September 9, 2008
Malignant intracranial germinoma in Smith-Lemli-Opitz syndrome: cholesterol homeostasis possibly connecting morphogenesis and cancer developmentHana Oslejskova, Vera Horinova, Jaroslav Sterba, et al.
World Journal of Oncology|November 18, 2017
Circulating Levels of Agouti-Related Peptide in Endometrial Cancer SurvivorsJulie Bienertova-Vasku, Josef Tomandl, Petr Bienert, et al.
Clinical Chemistry|July 27, 2002
Predicting response of ovarian cancer to paclitaxel treatment based on trend analysis of serum CA125Mirka Nekulova, Ladislav Pecen, Renata Kalabova, et al.
Clinical Chemistry|October 28, 2006
Surface-enhanced laser desorption ionization/time-of-flight mass spectrometry reveals significant artifacts in serum obtained from clot activator-containing collection devicesRadomir Pilny, Pavel Bouchal, Sarka Borilova, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
Gene expression of somatostatin receptor 4 predicts clinical outcome of patients with metastatic neuroendocrine tumors treated with somatostatin analogsOndrej Slaby, Milana Sachlova, Marketa Bednarikova, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2019
High prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR-directed monoclonal antibody (EXPAND trial) showing no prognostic impactRadka Obermannova, Dalibor Valik, Dirk Hasenclever, et al.
Onkologie|July 29, 2006
Combined biodifferentiating and antiangiogenic oral metronomic therapy is feasible and effective in relapsed solid tumors in children: single-center pilot studyJaroslav Sterba, Dalibor Valik, Peter Mudry, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Biomed Research International|September 5, 2015
B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related CachexiaMichal Rihacek, Julie Bienertova-Vasku, Dalibor Valik, et al.
Human Mutation|March 17, 2004
BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech RepublicLenka Foretova, Eva Machackova, Marie Navratilova, et al.
Anaerobe|June 1, 2011
Surface-enhanced laser desorption ionization/time-of-flight (SELDI-TOF) mass spectrometry (MS) as a phenotypic method for rapid identification of antibiotic resistanceLenka Dubska, Katerina Pilatova, Monika Dolejska, et al.
Journal of Pediatric Hematology/Oncology|September 9, 2008
Malignant intracranial germinoma in Smith-Lemli-Opitz syndrome: cholesterol homeostasis possibly connecting morphogenesis and cancer developmentHana Oslejskova, Vera Horinova, Jaroslav Sterba, et al.
World Journal of Oncology|November 18, 2017
Circulating Levels of Agouti-Related Peptide in Endometrial Cancer SurvivorsJulie Bienertova-Vasku, Josef Tomandl, Petr Bienert, et al.
Clinical Chemistry|July 27, 2002
Predicting response of ovarian cancer to paclitaxel treatment based on trend analysis of serum CA125Mirka Nekulova, Ladislav Pecen, Renata Kalabova, et al.
Clinical Chemistry|October 28, 2006
Surface-enhanced laser desorption ionization/time-of-flight mass spectrometry reveals significant artifacts in serum obtained from clot activator-containing collection devicesRadomir Pilny, Pavel Bouchal, Sarka Borilova, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
Gene expression of somatostatin receptor 4 predicts clinical outcome of patients with metastatic neuroendocrine tumors treated with somatostatin analogsOndrej Slaby, Milana Sachlova, Marketa Bednarikova, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2019
High prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR-directed monoclonal antibody (EXPAND trial) showing no prognostic impactRadka Obermannova, Dalibor Valik, Dirk Hasenclever, et al.
Onkologie|July 29, 2006
Combined biodifferentiating and antiangiogenic oral metronomic therapy is feasible and effective in relapsed solid tumors in children: single-center pilot studyJaroslav Sterba, Dalibor Valik, Peter Mudry, et al.
Pageof 5